Li Yizhuo

Li Zhang is a specialist at Sun Yat-sen University Cancer Center, where he is listed as Professor and PhD Supervisor and also serves as Deputy Director of the Lung Cancer Research Institute. His profile highlights a career spanning over 40 years at the cancer center, with a focus on lung cancer and nasopharyngeal carcinoma (NPC). Within medical oncology, his work integrates precision oncology strategies with drug development research. The profile describes his involvement in Phase I–III clinical trials for ADCs, bispecific antibodies, and immunotherapies, reflecting a translational pathway from molecular strategy to clinical testing. He also has supportive care research interests, including cancer pain management and prevention of chemotherapy-induced nausea. For international patients, this combination matters when treatment decisions must balance tumor control with quality-of-life outcomes.

Education

Education details are not specified in the provided profile materials.

Work experience

• Over 40 years at Sun Yat-sen University Cancer Center (medical oncology career, as stated).
• Deputy Director, Lung Cancer Research Institute, Sun Yat-sen University Cancer Center (as listed).

Clinical focus and techniques

At Sun Yat-sen University Cancer Center, Li Zhang’s clinical and research focus is on oncology drug development and precision treatment strategies for lung cancer and NPC.

• Targeted therapy for lung cancer (as part of his oncology treatment research profile).
• Immunotherapy for lung cancer (as part of his oncology treatment research profile).

Professional societies and certifications

Memberships and certifications are not specified in the provided profile materials.

Academic output

Publication metrics are not specified in the provided profile materials.

Courses and advanced training

Courses and advanced training are not specified in the provided profile materials.

Awards and recognition

Awards are not specified in the provided profile materials.

As a specialist at Sun Yat-sen University Cancer Center, Li Zhang supports international patients through precision oncology and clinical trial leadership for lung cancer and NPC. The profile materials do not specify spoken languages.